0000950170-22-017566.txt : 20220818 0000950170-22-017566.hdr.sgml : 20220818 20220817190110 ACCESSION NUMBER: 0000950170-22-017566 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20220815 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ITEM INFORMATION: Other Events FILED AS OF DATE: 20220818 DATE AS OF CHANGE: 20220817 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HCW Biologics Inc. CENTRAL INDEX KEY: 0001828673 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 825024477 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40591 FILM NUMBER: 221175851 BUSINESS ADDRESS: STREET 1: 2929 N COMMERCE PKWY CITY: MIRAMAR STATE: FL ZIP: 33025 BUSINESS PHONE: 954-842-2024 MAIL ADDRESS: STREET 1: 2929 N COMMERCE PKWY CITY: MIRAMAR STATE: FL ZIP: 33025 8-K 1 hcwb-20220815.htm 8-K 8-K
false000182867300018286732022-08-152022-08-15

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 15, 2022

 

 

HCW Biologics Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-40591

82-5024477

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

2929 N. Commerce Parkway

 

Miramar, Florida

 

33025

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 954 842-2024

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, par value $0.0001 per share

 

HCWB

 

The NASDAQ Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

 

 

Item 1.01 Entry into a Material Definitive Agreement.

On August 15, 2022, HCW Biologics Inc. (“HCW Biologics” or the “Company”) entered into a loan agreement (the “Loan Agreement”) with Cogent Bank to partially fund its purchase of a 36,000 square foot building (the “Corporate Headquarters”) located in Miramar, Florida, for $9.9 million. The Loan Agreement provides for a term loan of up to $6.5 million. The term loan is evidenced by a promissory note (the “Note”) bearing interest at a rate per annum equal to 5.75%, and maturing in August 2027. The Company will make interest-only payments on the term loan from September 2022 through August 2023 and will make principal and interest payments in 47 equal monthly installments, based on a 25-year maturity schedule, commencing September 15, 2023 followed by one final balloon payment of all remaining principal, interest and fees due on the maturity date of August 15, 2027. The Company’s obligations under the Loan Agreement are secured by, among other things, a mortgage on Corporate Headquarters and related real property located in Broward County, Florida, pursuant to a mortgage and security agreement, dated August 15, 2022, between the parties (the “Mortgage and Security Agreement”).

 

The Company also has the option to prepay the term loan under the Loan Agreement at any time without penalty. The Loan Agreement and Mortgage and Security Agreement (collectively, the “Loan Documents”) contain customary representations and warranties and affirmative covenants, and provide that the Company may borrow up to $6.5 million of additional funds, subject to full lending approval and review by the lender. The Loan Documents contain customary events of default, including, among others: non-payment of principal, interest or other amounts when due; provision of false or misleading of representations and information; certain pending litigation against the Company; certain judgments against the Company; the Company’s failure to subordinate other indebtedness to indebtedness owed to the lender; the lender deems itself or the prospect of payment and/or performance under the Loan Documents insecure; Dr. Hing C. Wong ceasing to own at least 20% of the voting interest in the Company or be its chief executive officer; bankruptcy, insolvency or inability to pay debts; and a change of control of the Company. Upon the occurrence and during the continuance of an event of default, the interest rate on the borrowing increases by 1225 basis points and the lender may terminate the commitments under the Loan Agreement and declare the loans and all other obligations under the Credit Facility immediately due and payable.

 

The description of the Loan Documents contained herein does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Loan Documents, copies of which will be filed as exhibits to the Company’s next quarterly report on Form 10-Q.

 

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

The information provided in response to Item 1.01 of this report is incorporated by reference into this Item 2.03.

 

Item 8.01 Other Events.

 

In connection with its entry into the Loan Documents, the Company contemporaneously entered a short-term lease with the former owner of the Corporate Headquarters for approximately 14,000 square feet of office space. The Corporate Headquarters will house the Company’s executive offices, lab space, and manufacturing facility. The Company plans to buildout the lab space and manufacturing facility over the course of the next 18 months. The Company intends to continue operations at its current location until its lease expires on February 28, 2024.

 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

HCW BIOLOGICS INC.

 

 

 

 

Date:

August 17, 2022

By:

 /s/ Hing C. Wong

 

 

 

Hing C. Wong, Ph.D., Founder and CEO

 

 EX-101.SCH 2 hcwb-20220815.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 100000 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.PRE 3 hcwb-20220815_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EX-101.LAB 4 hcwb-20220815_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Cover [Abstract] Amendment Flag City Area Code Document Period End Date Document Type Entity Address, Address Line One Entity Address, City or Town Entity Address, Postal Zip Code Entity Address, State or Province Entity Central Index Key Entity Emerging Growth Company Entity Ex Transition Period Entity File Number Entity Incorporation, State or Country Code Entity Registrant Name Entity Tax Identification Number Local Phone Number Pre-commencement Issuer Tender Offer Pre-commencement Tender Offer Title of 12(b) Security Security Exchange Name Soliciting Material Trading Symbol Written Communications XML 5 R1.htm IDEA: XBRL DOCUMENT v3.22.2.2
Document And Entity Information
Aug. 15, 2022
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Aug. 15, 2022
Entity Registrant Name HCW Biologics Inc.
Entity Central Index Key 0001828673
Entity Emerging Growth Company true
Entity File Number 001-40591
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 82-5024477
Entity Address, Address Line One 2929 N. Commerce Parkway
Entity Address, City or Town Miramar
Entity Address, State or Province FL
Entity Address, Postal Zip Code 33025
City Area Code 954
Local Phone Number 842-2024
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Ex Transition Period true
Title of 12(b) Security Common Stock, par value $0.0001 per share
Trading Symbol HCWB
Security Exchange Name NASDAQ
XML 6 hcwb-20220815_htm.xml IDEA: XBRL DOCUMENT 0001828673 2022-08-15 2022-08-15 false 0001828673 8-K 2022-08-15 HCW Biologics Inc. DE 001-40591 82-5024477 2929 N. Commerce Parkway Miramar FL 33025 954 842-2024 false false false false Common Stock, par value $0.0001 per share HCWB NASDAQ true true EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

M-8?20$3;8T.P6BP^0"X99K>]9!:G7&BN"^)]NK+NY *W3"W M\RQ+50/>I"MJ(-.)_#1EZA$VY8<1(86>Y4)88TS<;_3\1C0>09:'[L#TA(XA M+@W#"CTN*+N@U6/@24DM0H#E>QV3N7TR@ZN6>1>9!CG*(.XLH/P4:V%&@/8-SF0 M!)?DJG547>EYIM M[IFBG#S^0W1UW6E\./VR./ /,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9 MBBJ6<%H@XLD@;6E6?;!/3K3G>1,)KM\,<'AT_@%02P,$% @ M))@15660>9(9 0 SP, !, !;0V]N=&5N=%]4>7!E&ULK9--3L,P M$(6O$F5;)2XL6*"F&V +77 !8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>L MWH\1L.B=]=B4'5%\% )5!TYB'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH M>Y3KU3.T.EY&TWP39G 8ED\C<+,:DH9HS5*$M?%P>L?E.I$J+EST&!G M(BY84(JKA%SY'7#J>SM 2D9#L9&)7J5CE>BM0#I:P'K:XLH90]L:!3JHO>.6 M&F,"J;$#(&?KT70Q32:>,(S/N]G\P68*R,I-"A$YL01_QYTCR=U59"-(9*:O M>"&R]>S[04Y;@[Z1S>/]#&DWY(%B6.;/^'O&%_\;SO$1PNZ_/[&\UDX:?^:+ MX3]>?P%02P$"% ,4 " DF!%5!T%-8H$ "Q $ M@ $ 9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0 ( "28$54!QK*5[@ M "L" 1 " :\ !D;V-0&UL4$L! A0#% @ ))@15;/U$B!K! +Q$ !@ M ("!#0@ 'AL+W=O 1 !X;"]?7!E&UL4$L%!@ 0 ) D /@( \4 $! end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 1 23 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document And Entity Information Sheet http://hcwbiologics.com/20220815/taxonomy/role/DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false All Reports Book All Reports hcwb-20220815.htm hcwb-20220815.xsd hcwb-20220815_lab.xml hcwb-20220815_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "hcwb-20220815.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "hcwb-20220815.htm" ] }, "labelLink": { "local": [ "hcwb-20220815_lab.xml" ] }, "presentationLink": { "local": [ "hcwb-20220815_pre.xml" ] }, "schema": { "local": [ "hcwb-20220815.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "hcwb", "nsuri": "http://hcwbiologics.com/20220815", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "hcwb-20220815.htm", "contextRef": "C_60507120-4f3d-48e8-83a1-aade7e25790b", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document And Entity Information", "role": "http://hcwbiologics.com/20220815/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "hcwb-20220815.htm", "contextRef": "C_60507120-4f3d-48e8-83a1-aade7e25790b", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hcwbiologics.com/20220815/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hcwbiologics.com/20220815/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hcwbiologics.com/20220815/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hcwbiologics.com/20220815/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hcwbiologics.com/20220815/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hcwbiologics.com/20220815/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hcwbiologics.com/20220815/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hcwbiologics.com/20220815/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hcwbiologics.com/20220815/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hcwbiologics.com/20220815/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hcwbiologics.com/20220815/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hcwbiologics.com/20220815/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hcwbiologics.com/20220815/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hcwbiologics.com/20220815/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hcwbiologics.com/20220815/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hcwbiologics.com/20220815/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hcwbiologics.com/20220815/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hcwbiologics.com/20220815/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hcwbiologics.com/20220815/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hcwbiologics.com/20220815/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hcwbiologics.com/20220815/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hcwbiologics.com/20220815/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hcwbiologics.com/20220815/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r7": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" } }, "version": "2.1" } ZIP 13 0000950170-22-017566-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-22-017566-xbrl.zip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end